Operates Mykinso, a home gut microbiota test with personalized prevention solutions.
| Date | Round | Amount |
|---|---|---|
| Apr 2026 | Series D Plus Cykinso completed its Series D with a second close of the extension round (amount undisclosed) subscribed by Inno Associates and regional funds. | — |
| Aug 2024 | Series D Plus Cykinso, which runs the Mykinso gut-microbiome test, raised a Series D extension from Nittobo, Nihonkai Lab and Fuji Nihon Seito, taking the Series D total to about 1.15B JPY and cumulative funding to about 2.65B JPY. | $2.3M |
| Jul 2023 | Series D Plus Gut-microbiome testing company Cykinso (Mykinso) raised JPY 800M in a Series D; cumulative funding reached about JPY 2.3B. | $5.5M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.